Theofilis P, Oikonomou E, Tsioufis K, Tousoulis D. Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors. Life (Basel) 2023;13. [PMID: 36836854 DOI: 10.3390/life13020497][Reference Citation Analysis]
2
Patoulias D, Fragakis N, Rizzo M. The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest. Life (Basel) 2022;12. [PMID: 36556427 DOI: 10.3390/life12122062][Reference Citation Analysis]
3
Scheen AJ. Dissecting the reduction in cardiovascular death with SGLT2 inhibitors: Potential contribution of effects on ventricular arrhythmias and sudden cardiac death? Diabetes Epidemiology and Management 2022;8:100107. [DOI: 10.1016/j.deman.2022.100107][Reference Citation Analysis]